Human volunteer study on the inhalational and dermal absorption of N-methyl-2-pyrrolidone (NMP) from the vapour phase

Archives of Toxicology

Volumn 82, Issue 1, 2008, Pages 13-20

  Bader, Michael ^a   Wrbitzky, Renate ^a   Blaszkewicz, Meinolf ^b   Schäper, Michael ^b   Van Thriel, Christoph ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

Author keywords

Biomonitoring; Dermal absorption; GC MS; N Methyl 2 pyrrolidone

Indexed keywords

1 METHYL 2 PYRROLIDINONE; 2 HYDROXY N METHYLSUCCINIMIDE; 2 PYRROLIDONE DERIVATIVE; 5 HYDROXY N METHYL 2 PYRROLIDONE; SUCCINIMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOLOGICAL MONITORING; CONTROLLED STUDY; GAS CHROMATOGRAPHY; HALF LIFE TIME; HUMAN; HUMAN EXPERIMENT; INHALATION; MALE; MASS SPECTROMETRY; METABOLITE; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SKIN ABSORPTION; TOXICOKINETICS; VAPOR; WHOLE BODY AUTORADIOGRAPHY; WORK ENVIRONMENT; WORKLOAD;

ADULT; BIOTRANSFORMATION; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HALF-LIFE; HUMANS; INHALATION EXPOSURE; MALE; PYRROLIDINONES; SKIN ABSORPTION;

EID: 38349116598     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-007-0230-5     Document Type: Article

References (33)

1. ACGIH (American Conference of Governmental Industrial Hygienists) (2007) Threshold limit values and biological exposure indices. Signature Publications, ISBN 978-1-882417-69-8
2. Åkesson B (2001) N-methyl-2-pyrrolidone. Concise International Chemical Assessment Document 35, World Health Organization, Geneva, ISBN 9 241 53035 9
3. Åkesson B, Jönsson BAG (1997) Major metabolic pathway for N-methyl-2-pyrrolidone in humans. Drug Metab Dispos 25:267-269
4. Åkesson B, Jönsson BAG (2000) Biological monitoring of N-methyl-2-pyrrolidone using 5-hydroxy-N-methyl-2-pyrrolidone in plasma and urine as the biomarker. Scand J Work Environ Health 26:213-218
5. Åkesson B, Carnerup M, Jönsson BAG (2004) Evaluation of exposure biomarkers from percutaneous absorption of N-methyl-2-pyrrolidone. Scand J Work Environ Health 30:306-312
6. Akrill P, Cocker J, Dixon S (2002) Dermal exposure to aqueous solutions of N-methylpyrrolidone. Toxicol Lett 134:265-269
7. Anundi H, Lind ML, Friis L, Itkes N, Langworth S, Edling C (1993) High exposures to organic solvents among graffiti removers. Int Arch Occup Environ Health 65:247-251
8. Anundi H, Langworth S, Johanson G, Lind ML, Åkesson B, Friis L, Itkes N, Söderman E, Jönsson BAG, Edling C (2000) Air and biological monitoring of solvent exposure during graffiti removal. Int Arch Occup Environ Health 73:561-569
9. Bader M, Keener SA, Wrbitzky R (2005) Dermal absorption and urinary elimination of N-methyl-2-pyrrolidone. Int Arch Occup Environ Health 78:673-676
10. Bader M, Rosenberger W, Rebe Th, Keener S, Brock TH, Hemmerling H, Wrbitzky R (2006a) Ambient monitoring and biomonitoring of workers exposed to N-methyl-2-pyrrolidone (NMP) in an industrial facility. Int Arch Occup Environ Health 79:357-364
11. Bader M, Wrbitzky R, Blaszkewicz M, van Thriel Ch (2006b) Human experimental exposure study on the uptake and urinary elimination of N-methyl-2-pyrrolidone (NMP) during simulated workplace conditions. Arch Toxicol 81:335-346
12. Beaulieu HJ, Schmerber KR (1991) M-Pyrol™ (NMP) use in the microelectronics industry. Appl Occup Environ Hyg 6:874-880
13. Brooke I, Cocker J, Delic JI, Payne M, Jones K, Gregg NC, Dyne D (1998) Dermal uptake of solvents from the vapour phase: an experimental study in humans. Ann Occup Hyg 8:531-540
14. Carnerup MA (2004) Analysis, metabolism, effects and biological monitoring of N-methyl-2-pyrrolidone (NMP). Thesis, Faculty of Medicine, Lund University, Sweden
15. Carnerup MA, Spanne M, Jönsson BAG (2006) Levels of N-methyl-2-pyrrolidone (NMP) and its metabolites in plasma and urine from volunteers after experimental exposure to NMP in dry and humid air. Toxicol Lett 162:139-45
16. Cocker J, Akrill P, Bagon D, Roff M, Warren N (2004) Biological monitoring of exposure to N-methyl-2-pyrrolidone during graffiti and paint removal. In: 6th International symposium on biological monitoring in occupational and environmental Health, Heidelberg
17. DFG (Deutsche Forschungsgemeinschaft) (2006) N-Methyl-2-pyrrolidon. In: Greim H (ed) Gesundheitsschädliche Arbeitsstoffe. Toxikologisch- arbeitsmedizinische Begründungen von MAK-Werten. Suppl 41. Wiley, Weinheim
18. DFG (Deutsche Forschungsgemeinschaft) (2007) List of MAK and BAT values. Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area. Report No. 43, Wiley, Weinheim
19. HSE (Health and Safety Executive) (1997) N-Methyl-2-pyrrolidone. Risk assessment document. EH72/10, ISBN 0717615286, HSE Books, Sudbury
20. Jones K, Cocker J, Dodd LJ, Fraser I (2003) Factors influencing the extent of dermal absorption of solvent vapours: a human volunteer study. Ann Occup Hyg 47:145-150
21. Jönsson BAG, Åkesson B (2003) Human experimental exposure to N-methyl-2-pyrrolidone (NMP): toxicokinetics of NMP, 5-hydroxy-N-methyl-2- pyrrolidone, N-methylsuccinimide and 2-hydroxy-N-methylsuccinimide (2-HMSI), and biological monitoring using 2-HMSI as a biomarker. Int Arch Occup Environ Health 76:267-274
22. Keener SA, Wrbitzky R, Bader M (2006) Human volunteer study on the influence of exposure duration and dilution of dermally applied N-methyl-2-pyrrolidone (NMP) on the urinary elimination of NMP metabolites. Int Arch Occup Environ Health 80:327-334
23. Kežić S, Mahieu K, Monster AC, de Wolff FA (1997) Dermal absorption of vaporous and liquid 2-methoxyethanol and 2-ethoxyethanol in volunteers. Occup Environ Med 54:38-43
24. Korinth G, Göen Th, Lakemeyer M, Broding HC, Drexler H (2003) Skin strain and its influence on systemic exposure to a glycol ether in offset printing workers. Contact Derm 49:248-254
25. Langworth S, Anundi H, Friis L, Johanson G, Lind ML, Söderman E, Åkesson B (2001) Acute health effects common during graffiti removal. Int Arch Occup Environ Health 74:213-218
26. Loizou GD, Jones K, Akrill P, Dyne D, Cocker J (1999) Estimation of the dermal absorption of m-xylene vapor in humans using breath sampling and physiologically based pharmacokinetic analysis. Toxicol Sci 48:170-179
27. Rawson BV, Cocker J, Evans PG, Wheeler JP, Akrill PM (2005) Internal containtion of gloves: routes and consequences. Ann Occup Hyg 49:535-541
28. Riihimäki V, Pfäffli P (1978) Percutaneous absorption of solvent vapors in man. Scand J Work Environ Health 4:73-85
29. Saillenfait AM, Gallissot F, Langonne I, Sabate JP (2002) Developmental toxicity of N-methyl-2-pyrrolidone administered orally to rats. Food Chem Toxicol 40:1705-1712
30. Saillenfait AM, Gallissot F, Morel G (2003) Developmental toxicity of N-methyl-2-pyrrolidone in rats following inhalation exposure. Food Chem Toxicol 41:583-588
31. Ursin C, Hansen CM, Van Dyk JW, Jensen PO, Christensen IJ, Ebbehoej J (1995) Permeability of commercial solvents through living human skin. Am Ind Hyg Assoc J 56:651-660
32. Wilkinson SC, Williams FM (2002) Effects of experimental conditions on absorption of glycol ethers through human skin in vitro. Int Arch Occup Environ Health 75:519-527
33. Wrbitzky R, Angerer J (1998) N,N-dimethylformamide-influence of working conditions and skin penetration on the internal exposure of workers in synthetic textile production. Int Arch Occup Environ Health 71:309-316